<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/64300AF7-F2A5-4EEC-983A-CC4168C9C664"><gtr:id>64300AF7-F2A5-4EEC-983A-CC4168C9C664</gtr:id><gtr:name>Virginia Commonwealth University</gtr:name><gtr:address><gtr:line1>Virginia Commonwealth University</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Immunology Infection and Inflam Diseases</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64300AF7-F2A5-4EEC-983A-CC4168C9C664"><gtr:id>64300AF7-F2A5-4EEC-983A-CC4168C9C664</gtr:id><gtr:name>Virginia Commonwealth University</gtr:name><gtr:address><gtr:line1>Virginia Commonwealth University</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CAA725BA-A98D-482C-BBAB-91827918EFDD"><gtr:id>CAA725BA-A98D-482C-BBAB-91827918EFDD</gtr:id><gtr:firstName>Ralph</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Linden</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001764"><gtr:id>6A43BBE0-CD90-4487-8516-60A9F01D2C21</gtr:id><gtr:title>Strategies of viral multi-functional regulator proteins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001764</gtr:grantReference><gtr:abstractText>In order to replicate viruses have evolved a panoply of mechanisms to overcome and, in many cases utilize components of complex host pathways. In order to successfully orchestrate the cellular environment for the support of viral infection and replication and based on their inherently small genome sizes many viruses have adopted approaches that incorporate multiple functions into single proteins. In this application we propose to study mechanisms by which the adeno-associated virus Rep protein can regulate its many activities.</gtr:abstractText><gtr:technicalSummary>In order to productively replicate viruses have evolved a panoply of mechanisms to overcome and, in many cases utilize components of complex host pathways. In order to successfully orchestrate the cellular environment for the support of viral replication and based on their inherently limited genome sizes many viruses have adopted approaches that incorporate multiple functions into single proteins. This application aims to dissect the molecular bases for the coordination of the multiple functions that the Rep protein from the human adeno-associated virus (AAV) utilizes in order to support its complex lifestyle. Furthermore, this application is a component of a collaboration with a US laboratory that has recently been funded to determine the structures and biophysical characteristics of AAV Rep complexes. Our UK component outlined here aims at dissecting the functional relevance of these complexes within the context of the viral life cycle.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>553448</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Virginia Commonwealth University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Strategies of viral multi-functional regulator proteins</gtr:description><gtr:id>655AFB3C-3ED5-4E3E-AB5E-EDF7967E4F5C</gtr:id><gtr:impact>22719256
19593381
15371437
15310852
2906833</gtr:impact><gtr:outcomeId>ZLYFSD2qivm-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator contributes to the structural analyses which our team used to discern biological function.</gtr:partnerContribution><gtr:piContribution>This collaboration is aimed at a structure-function determination of the viral AAV Rep proteins. We provide the biological insights.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>Sweden, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Hepatic synthesis of L=DOPA</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Genepod Therapeutics?AB</gtr:fundingOrg><gtr:id>925BDCBC-8CAB-46D6-9E3F-DBF8DE72D226</gtr:id><gtr:outcomeId>hxAs1WHVgkP</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>House of Lords Select Committee Science and Technology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>043D8AFE-FCF4-491C-91BF-46B68B43348E</gtr:id><gtr:outcomeId>PRCRTMgNxPb</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D7326833-8518-4139-B0D8-1FA0E39455FD</gtr:id><gtr:title>Presence of a trs-Like Motif Promotes Rep-Mediated Wild-Type Adeno-Associated Virus Type 2 Integration.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d188f6d56f0721bb1f852783a49a4fd9"><gtr:id>d188f6d56f0721bb1f852783a49a4fd9</gtr:id><gtr:otherNames>Petri K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>55b77eef22fb08.20917871</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60D9B5EF-F296-4F20-9DA3-E61A6FB90499</gtr:id><gtr:title>Adeno-associated virus biology.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a041337c4511b98b931c231cdb0a8f70"><gtr:id>a041337c4511b98b931c231cdb0a8f70</gtr:id><gtr:otherNames>Weitzman MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>sSBjTMfecLC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2F45C8C-0994-48D9-861E-6CABDA30DBB7</gtr:id><gtr:title>Comparative next-generation sequencing of adeno-associated virus inverted terminal repeats.</gtr:title><gtr:parentPublicationTitle>BioTechniques</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d188f6d56f0721bb1f852783a49a4fd9"><gtr:id>d188f6d56f0721bb1f852783a49a4fd9</gtr:id><gtr:otherNames>Petri K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0736-6205</gtr:issn><gtr:outcomeId>5464cd3cd1d3b6.91474856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A656BDFD-136F-4030-A88D-8B6A3CE99DB6</gtr:id><gtr:title>Oligomeric properties of adeno-associated virus Rep68 reflect its multifunctionality.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6154b104f9f4d9e5f9b92a12338aa5ed"><gtr:id>6154b104f9f4d9e5f9b92a12338aa5ed</gtr:id><gtr:otherNames>Zarate-Perez F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>Rg1D8gqJB8n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDA79DEF-E69B-4F9F-9FA2-14A5B649BD3E</gtr:id><gtr:title>Adeno-associated virus Rep represses the human integration site promoter by two pathways that are similar to those required for the regulation of the viral p5 promoter.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/474b108d1d71df7f8073aa829bda661e"><gtr:id>474b108d1d71df7f8073aa829bda661e</gtr:id><gtr:otherNames>Dutheil N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5464cd1c18e6d2.46598241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAF2ED6E-11D1-4F8F-8904-F83302D69AD6</gtr:id><gtr:title>Analysis of Replicative Intermediates of Adeno-associated Virus through Hirt Extraction and Southern Blotting.</gtr:title><gtr:parentPublicationTitle>Bio-protocol</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0ecc01e13b8613ebf6611c22283acbc"><gtr:id>d0ecc01e13b8613ebf6611c22283acbc</gtr:id><gtr:otherNames>Bardelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2331-8325</gtr:issn><gtr:outcomeId>5a31d8671ee148.05956496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AB175CA-C887-4CF6-96C1-368FBD6983DB</gtr:id><gtr:title>The interdomain linker of AAV-2 Rep68 is an integral part of its oligomerization domain: role of a conserved SF3 helicase residue in oligomerization.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6154b104f9f4d9e5f9b92a12338aa5ed"><gtr:id>6154b104f9f4d9e5f9b92a12338aa5ed</gtr:id><gtr:otherNames>Zarate-Perez F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_14912_22_22719256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D30F12D-D20C-4B73-B86B-F339B3F6B9AA</gtr:id><gtr:title>Quantification of AAV particle titers by infrared fluorescence scanning of coomassie-stained sodium dodecyl sulfate-polyacrylamide gels.</gtr:title><gtr:parentPublicationTitle>Human gene therapy methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7363314e97ba01b0c87738a4dbb305d1"><gtr:id>7363314e97ba01b0c87738a4dbb305d1</gtr:id><gtr:otherNames>Kohlbrenner E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1946-6536</gtr:issn><gtr:outcomeId>pm_14912_22_22816378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C54E986B-B334-4AE7-A317-C725E172B96B</gtr:id><gtr:title>Adeno-associated virus: a key to the human genome?</gtr:title><gtr:parentPublicationTitle>Future virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83401f54a23f9530058c212ba4cdb24e"><gtr:id>83401f54a23f9530058c212ba4cdb24e</gtr:id><gtr:otherNames>Henckaerts E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1746-0794</gtr:issn><gtr:outcomeId>rKRfgP6Cuv3</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001764</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>